Treatment and Outcomes for Congestive Heart Failure by Race/Ethnicity in TRICARE

Background: Equitable access to health insurance coverage may improve outcomes of care for chronic health conditions and mitigate racial/ethnic health disparities. This study examines racial/ethnic disparities in the treatment and outcomes of care for TRICARE beneficiaries with congestive heart fail...

Full description

Saved in:
Bibliographic Details
Published in:Medical care 2011-05, Vol.49 (5), p.489-495
Main Authors: Bagchi, Ann D., Stewart, Kate, McLaughlin, Catherine, Higgins, Patricia, Croghan, Thomas
Format: Article
Language:English
Subjects:
Adolescent
Adrenergic beta-Antagonists - therapeutic use
Adult
African Americans
African Americans - statistics & numerical data
Aged
Angiotensin Receptor Antagonists - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Beneficiaries
Beta blockers
Cardiovascular disease
Comorbidity
Congestive heart failure
Continental Population Groups - statistics & numerical data
Drug therapy
Ethnic Groups - statistics & numerical data
Ethnicity
European Continental Ancestry Group - statistics & numerical data
Female
Health care industry
Health insurance
Health outcomes
Healthcare Disparities - statistics & numerical data
Heart Failure - drug therapy
Heart Failure - ethnology
Hispanic Americans - statistics & numerical data
Hispanics
Hospitalization
Hospitalization - statistics & numerical data
Humans
Male
Medical treatment
Middle Aged
Multivariate Analysis
Pharmacology
Retrospective Studies
Treatment Outcome
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Equitable access to health insurance coverage may improve outcomes of care for chronic health conditions and mitigate racial/ethnic health disparities. This study examines racial/ethnic disparities in the treatment and outcomes of care for TRICARE beneficiaries with congestive heart failure (CHF). Methods: Using a retrospective cohort analysis, we examined demographic characteristics, sources of care, and comorbid conditions for 2183 beneficiaries of the Military Health System's TRICARE program (representing 115,584 beneficiaries after adjusting for survey weights) with CHF. Treatments included use of CHF-related medications, while the outcome of interest was any CHF-related potentially avoidable hospitalizations (PAHs). Results: While African Americans were less likely than whites to have received beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers following a CHF diagnosis (P
ISSN:0025-7079
1537-1948
DOI:10.1097/MLR.0b013e318207ef87